References in periodicals archive ?
Several investigators have revealed that the nanostructure influences the adhesion, differentiation, and migration of bone marrow cells significantly [9-12] and that the fates of cells on NT arrays are size dependent [9, 13, 14], while the optimal diameter is still controversial.
At present, whether or not FA can induce the increase of micronucleus rate in animal cells is still controversial.5 It was reported that short time inhalation of FA can induce the increase of micronucleus rate in bone marrow cells of exposed mice.6-8 Our recent studies showed that the micronucleus rate of bone marrow cells in the experimental mice was increased by acute oral administration of FA.9 In the present study, the male mice were chronically exposed to FA through inhalation.
The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method.
Cleveland Clinic cardiologist Marc Penn, MD, PhD, a leading researcher in stem cell therapy, says he's confident that heart patients around the world could start to experience improved heart function triggered by bone marrow cells harvested from their own bodies.
Induction of calcitonin receptors by 1[alpha], 25-dihydroxyvitamin [D.sub.3] in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 1988;123:1504-10.
Under these circumstances, to decrease the incidence and the severity of this complication, the donor bone marrow cells are cleansed of a particular population of cells (known as T cells) that are thought to cause GVHD.
"The importance of the present study is that it shows that intracoronary delivery of bone marrow cells improves function and flow in patients with old myocardial infarction.
Washington, June 30 (ANI): A new study has found that an extract derived from bone marrow cells is as effective as therapy using bone marrow stem cells for improving cardiac function after a heart attack.
[USA], Jan 31 (ANI): A new study, from the University of East Anglia, now finds that leukaemia promotes premature ageing in healthy bone marrow cells.
HSCT is an intravenous infusion of bone marrow cells to patients with a variety of acquired and inherited malignant and non-malignant disorders including blood cancer, sickle cell disease and thalassaemia.
One of the most used technology is by the recovery of bone marrow cells as the production of new cells from bone marrow stem cells is faster.
Gene therapy, which has shown promise in other blood disorders, would require extracting bone marrow cells, correcting them, and transplanting them back to the patient, a difficult process for FA patients with fragile bone marrow cells.